Managed Care Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hannover Medical School
Researchers describe findings in transplant medicine studies
August 16th, 2005
Transplant medicine research advances have been reported from Germany, the United Kingdom and Italy. Study 1: Select therapies limit fibrosis progression after liver transplantation. According to recent research from Germany, "in a substantial proportion of patients, recurrent hepatitis C after liver transplantation (OLT) rapidly progresses to graft cirrhosis. The role of different immunosuppressive schemes is not well evaluated." "The clinical course of 130 patients with recurrent hepatitis C after OLT was retrospectively analyzed. Mean trough levels of calcineurin inhibitors and cumulative doses of the remaining...
Source: Managed Care Business Week (2005-08-16)
|
